In the News

C4X Discovery fully cashed up and sees big potential for its 'blockbuster molecules'

Clive Dix speaks to Proactive London's Andrew Scott following the news they've raised around £6.6mln to strengthen its balance sheet amid ongoing licensing discussions for its early-stage drug candidates.